The Role of the Liver in the Pathophysiology of PCOS: A Literature Review

The Role of the Liver in the Pathophysiology of PCOS: A Literature Review

Polycystic ovary syndrome (PCOS) is the most common endocrine metabolic disorder found in women of reproductive age and is characterized by both metabolic and reproductive dysfunction. Women with PCOS commonly have insulin resistance, increased susceptibility to type 2 diabetes mellitus, dyslipidemi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abrar Alhermi, Heather Perks, Varsha Nigi, Noor Altahoo, Stephen L. Atkin, Alexandra E. Butler
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomolecules
Subjects:	polycystic ovary syndrome (PCOS) insulin resistance nonalcoholic fatty liver disease (NAFLD) hepatokines non-coding RNA
Online Access:	https://www.mdpi.com/2218-273X/15/1/51
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
by: Imadeldin Elfaki, et al.
Published: (2025-01-01)

Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
by: Valentina N. Nikolić, et al.
Published: (2025-01-01)

Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-01-01)

The Use of Yoga in the Treatment of PCOS
by: Agnieszka Przesor Przezor, et al.
Published: (2025-01-01)

The role of diet and physical activity in PCOS - A Quick Review
by: Natalia Pawelec, et al.
Published: (2025-02-01)

Polycystic ovary syndrome in a patient with type B insulin resistance syndrome can improve with glucocorticoid treatment: a case report and literature review
by: Tetsuhiro Watanabe, et al.
Published: (2023-10-01)

Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
by: Zhenye Zhu, et al.
Published: (2025-01-01)

Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol
by: Alessandro D. Genazzani, et al.
Published: (2025-12-01)

Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets
by: Xuedan Lai, et al.
Published: (2025-02-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Whole Exome Sequencing Reveals Rare Variants in Genes Associated with Metabolic Disorders in Women with PCOS
by: Priyal Sharma, et al.
Published: (2023-10-01)

Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Study on the effects of Mogroside V in inhibiting NLRP3-mediated granulosa cell pyroptosis and insulin resistance to improve PCOS
by: Wenqin Yang, et al.
Published: (2025-01-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
by: Jingyi Yuan, et al.
Published: (2025-02-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
by: Wenying Qiao, et al.
Published: (2025-01-01)

Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study
by: Zhuyuan Zheng, et al.
Published: (2025-01-01)

Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
by: Mina Amiri, et al.
Published: (2025-02-01)

Woxuanzhongzhou formula improves DHEAS and high-fat diet-induced IR and anovulatory mice via AMPK/PGC1- α/Irisin pathway
by: Haijuan Liu, et al.
Published: (2025-01-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
by: Haoxiang Zhu, et al.
Published: (2025-01-01)

Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to In Vitro Fertilization Center: Case-Control Study
by: Neda Emami, et al.
Published: (2025-01-01)

Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
by: Tingting Kong, et al.
Published: (2023-10-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

Perceived Effects and Prevention of Polycystic Ovary Syndrome among Women Living in Ilorin-South LGA, Kwara State, Nigeria
by: Abdulqudus Tosin Jamiu, et al.
Published: (2024-12-01)

Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
by: Gulay Beydilli Nacak, et al.
Published: (2021-08-01)

Association between SPISE and NAFLD in patients with type 2 diabetes
by: Hongyan Zhao, et al.
Published: (2025-01-01)

Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)

The role of salivary antioxidant level in polycystic ovary syndrome women under assisted reproductive technology treatment: A case-control study
by: Narges Gholizadeh, et al.
Published: (2025-02-01)

Pulsed Low-Intensity Focused Ultrasound (LIFU) Activation of Ovarian Follicles
by: Yan Xiao, et al.
Published: (2024-01-01)

Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis
by: Xiaolin Zhu, et al.
Published: (2025-01-01)

Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome
by: Yong Liu, et al.
Published: (2025-12-01)

Association of TCF7L2 genetic variants rs12255372 and rs7903146 with the polycystic ovary syndrome risk: systematic review and meta-analysis
by: Idrees A. Shah, et al.
Published: (2025-01-01)

Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway
by: Hideki Kumagai, et al.
Published: (2024-02-01)

Does Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
by: Serkan Kahyaoglu, et al.
Published: (2023-08-01)

Comparison of the impact of intermittent fasting diet alone or in conjunction with probiotic supplementation versus calorie-restricted diet on inflammatory, oxidative stress, and antioxidant capacity biomarkers in women with polycystic ovary syndrome: A randomized placebo-controlled trial
by: Sepide Talebi, et al.
Published: (2025-01-01)